statistiche ricercatore

Continente	#
NA - Nord America	403
EU - Europa	269
SA - Sud America	245
AS - Asia	242
AF - Africa	13
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.173

Nazione	#
US - Stati Uniti d'America	387
BR - Brasile	223
SG - Singapore	115
DE - Germania	105
FI - Finlandia	73
CN - Cina	44
IT - Italia	43
HK - Hong Kong	21
VN - Vietnam	14
AR - Argentina	11
CA - Canada	10
ES - Italia	7
PL - Polonia	7
RU - Federazione Russa	7
GB - Regno Unito	6
PK - Pakistan	6
TR - Turchia	6
IN - India	5
JP - Giappone	5
BD - Bangladesh	4
UY - Uruguay	4
AE - Emirati Arabi Uniti	3
AZ - Azerbaigian	3
CZ - Repubblica Ceca	3
FR - Francia	3
IQ - Iraq	3
KE - Kenya	3
LT - Lituania	3
MX - Messico	3
UZ - Uzbekistan	3
AT - Austria	2
CO - Colombia	2
EC - Ecuador	2
EG - Egitto	2
JM - Giamaica	2
JO - Giordania	2
KR - Corea	2
MA - Marocco	2
MK - Macedonia	2
PS - Palestinian Territory	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AO - Angola	1
BE - Belgio	1
CR - Costa Rica	1
DZ - Algeria	1
GR - Grecia	1
HU - Ungheria	1
IL - Israele	1
KG - Kirghizistan	1
LB - Libano	1
LU - Lussemburgo	1
MD - Moldavia	1
PE - Perù	1
SA - Arabia Saudita	1
SE - Svezia	1
TN - Tunisia	1
TZ - Tanzania	1
UA - Ucraina	1
ZA - Sudafrica	1
ZM - Zambia	1
Totale	1.173

Nome	#
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population	250
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists	123
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study	113
Influence of tetrathiafulvalene (TTF) and derivatives on redox state and cell viability of human endothelial cells	107
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience	106
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience	100
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era?	98
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression	90
Living with HIV and Getting Vaccinated: A Narrative Review	79
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort	64
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort	61
Totale	1.191

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2	0	0	0	0	0	0	0	0	0	0	0	2
2022/2023	72	1	9	2	8	6	17	3	6	6	1	8	5
2023/2024	47	6	4	2	3	20	1	3	0	1	0	2	5
2024/2025	579	7	0	28	10	10	43	76	108	162	99	27	9
2025/2026	491	36	170	59	123	95	8	0	0	0	0	0	0
Totale													1.191